Olaf Stuve
Section Head · University of Texas Southwestern Medical Center
Credentials: · · ·
History
- Present
Dallas VA Neurology Division · University of Texas Southwestern Medical Center
- 1998–2002
Neurology
- 1989–1993
Freie University Berlin (1993), Medicine
Research
Defining the clinical course of multiple sclerosis: the 2013 revisions
Neurology · 2014 · 2,440 citations
Nature · 2002 · 922 citations
The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review
Systematic review or meta-analysis · Journal of Multiple Sclerosis · 2015 · 376 citations
44 papers
- SZ
35 papers · 1 as a resident
- MR
33 papers
- TE
30 papers
20 papers
- AS
18 papers · 4 as a resident
- GC
16 papers
15 papers
Grants
- 2025–2027
Immune Checkpoint-Engineered Oligodendrocytes as Treatment for Multiple Sclerosis
National Institute of Allergy and Infectious Diseases · R56
PI · $300K · Ut Southwestern Medical Center
- 2021–2026
Defining the Role of CD11c+CD88+CD317+ Myeloid Cells as Mediators of CNS Autoimmunity
Department of Veterans Affairs · I01
Contact PI · Va North Texas Health Care System
- 2013–2016
Determining the Compartmental Role of B Cell Subsets During CNS Autoimmunity
Department of Veterans Affairs · I01
Contact PI · Va North Texas Health Care System
Clinical trials
- 2023–2026
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
Principal investigator · Active not recruiting · Phase 2
Dallas VA Medical Center
- 2020–2026
Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
Principal investigator · Active not recruiting · Phase 4
University of Texas Southwestern Medical Center
- 2018–2020
Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple Sclerosis
Principal investigator · Completed · Phase 4
University of Texas Southwestern Medical Center
- 2013
Alternative Treatment Paradigm for Natalizumab Trial
Principal investigator · Withdrawn · Phase 2
University of Texas Southwestern Medical Center